Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 6.37%5.71B | 10.30%10.97B | 23.69%5.36B | 22.04%9.95B | 5.99%4.34B | 8.16%8.15B | 9.03%4.09B | 19.96%7.54B | 31.94%3.75B | 12.42%6.28B |
| Operating income | 6.37%5.71B | 10.30%10.97B | 23.69%5.36B | 22.04%9.95B | 5.99%4.34B | 8.16%8.15B | 9.03%4.09B | 19.96%7.54B | 31.94%3.75B | 12.42%6.28B |
| Cost of sales | -17.68%-4.76B | -10.44%-8.64B | -15.08%-4.04B | -12.10%-7.83B | 1.16%-3.51B | -7.45%-6.98B | -13.43%-3.55B | -33.11%-6.5B | -40.03%-3.13B | -8.15%-4.88B |
| Operating expenses | -17.68%-4.76B | -10.44%-8.64B | -15.08%-4.04B | -12.10%-7.83B | 1.16%-3.51B | -7.45%-6.98B | -13.43%-3.55B | -33.11%-6.5B | -40.03%-3.13B | -8.15%-4.88B |
| Gross profit | -28.25%947.5M | 9.80%2.33B | 60.43%1.32B | 81.38%2.12B | 53.31%823.08M | 12.57%1.17B | -13.23%536.88M | -25.85%1.04B | 2.05%618.72M | 30.33%1.4B |
| Selling expenses | -4.60%-265.74M | 1.73%-517.04M | -3.30%-254.04M | -5.76%-526.16M | -10.60%-245.94M | -13.62%-497.49M | -4.26%-222.38M | -11.92%-437.85M | -17.32%-213.29M | -9.88%-391.23M |
| Administrative expenses | -31.88%-122.7M | -10.34%-235.96M | -14.90%-93.04M | -15.81%-213.84M | 15.88%-80.97M | -4.93%-184.64M | -3.18%-96.26M | -2.70%-175.97M | -19.51%-93.29M | -34.00%-171.33M |
| Research and development expenses | -2.78%-111.72M | -4.50%-250.75M | 14.23%-108.69M | -4.69%-239.95M | -12.88%-126.72M | 9.76%-229.2M | 5.70%-112.26M | -60.68%-253.98M | -73.69%-119.06M | -25.99%-158.06M |
| Impairment and provision | 71.35%-777K | -267.36%-5.09M | -388.20%-2.71M | 63.70%-1.39M | 397.88%941K | -141.92%-3.82M | --189K | 64.49%-1.58M | ---- | ---4.44M |
| -Other impairment is provision | 71.35%-777K | -267.36%-5.09M | -388.20%-2.71M | 63.70%-1.39M | 397.88%941K | -141.92%-3.82M | --189K | 64.49%-1.58M | ---- | ---4.44M |
| Special items of operating profit | 22.83%60.49M | 48.63%92.42M | 16.87%49.25M | -63.78%62.18M | -18.27%42.14M | 69.52%171.66M | -20.09%51.56M | 687.35%101.26M | 99.47%64.53M | -82.51%12.86M |
| Operating profit | -44.36%507.07M | 17.52%1.41B | 120.89%911.26M | 182.08%1.2B | 161.53%412.54M | 57.29%426.31M | -38.77%157.74M | -60.67%271.04M | -16.96%257.61M | 27.75%689.16M |
| Financing income | -73.95%6.51M | 66.08%34.23M | 160.31%24.97M | 138.83%20.61M | 217.65%9.59M | 14.38%8.63M | -44.93%3.02M | -48.18%7.54M | 42.44%5.48M | -16.19%14.56M |
| Financing cost | 74.32%-11.28M | 32.26%-63.07M | 0.68%-43.94M | -16.20%-93.11M | -59.37%-44.24M | -547.24%-80.13M | -4,993.76%-27.76M | -128.08%-12.38M | 72.60%-545K | 21.80%-5.43M |
| Share of profits of associates | 2,225.00%186K | -82.79%84K | -95.51%8K | 750.67%488K | 368.42%178K | 75.00%-75K | --38K | -300.00%-300K | ---- | -156.39%-75K |
| Earning before tax | -43.69%502.48M | 22.46%1.38B | 136.02%892.3M | 218.70%1.13B | 184.19%378.06M | 33.41%354.74M | -49.33%133.03M | -61.92%265.9M | -15.88%262.55M | 26.95%698.22M |
| Tax | 106.39%5.17M | 25.21%-72.63M | -58.80%-80.87M | -348.46%-97.11M | -299.23%-50.93M | 275.80%39.08M | 248.63%25.56M | 111.13%10.4M | 63.28%-17.2M | -32.98%-93.47M |
| After-tax profit from continuing operations | -37.44%507.65M | 26.94%1.31B | 148.04%811.43M | 162.41%1.03B | 106.27%327.14M | 42.53%393.82M | -35.36%158.6M | -54.31%276.3M | -7.51%245.35M | 26.06%604.75M |
| Earning after tax | -37.44%507.65M | 26.94%1.31B | 148.04%811.43M | 162.41%1.03B | 106.27%327.14M | 42.53%393.82M | -35.36%158.6M | -54.31%276.3M | -7.51%245.35M | 26.06%604.75M |
| Minority profit | 114.29%15K | -36.73%31K | 250.00%7K | 25.64%49K | -90.00%2K | 2,050.00%39K | 600.00%20K | 97.22%-2K | -105.88%-4K | ---72K |
| Profit attributable to shareholders | -37.44%507.63M | 26.94%1.31B | 148.04%811.42M | 162.43%1.03B | 106.29%327.13M | 42.52%393.78M | -35.37%158.58M | -54.32%276.3M | -7.48%245.35M | 26.08%604.82M |
| Basic earnings per share | -37.01%0.8 | 27.16%2.06 | 149.02%1.27 | 161.29%1.62 | 104.00%0.51 | 44.19%0.62 | -35.90%0.25 | -54.74%0.43 | -7.14%0.39 | 25.00%0.95 |
| Diluted earnings per share | -37.01%0.8 | 27.16%2.06 | 149.02%1.27 | 161.29%1.62 | 104.00%0.51 | 44.19%0.62 | -35.90%0.25 | -54.74%0.43 | -7.14%0.39 | 25.00%0.95 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PwC Accounting Firm | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.